Cargando…
“Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?
There is great interest in the application of ‘artificial intelligence’ (AI) to pharmacovigilance (PV). Although US FDA is broadly exploring the use of AI for PV, we focus on the application of AI to the processing and evaluation of Individual Case Safety Reports (ICSRs) submitted to the FDA Adverse...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112277/ https://www.ncbi.nlm.nih.gov/pubmed/35579808 http://dx.doi.org/10.1007/s40264-022-01157-4 |